Institutional shares held 161 Million
1.24M calls
183K puts
Total value of holdings $589M
$4.52M calls
$670K puts
Market Cap $1.18B
257,338,000 Shares Out.
Institutional ownership 62.52%
# of Institutions 249


Latest Institutional Activity in MNKD

Top Purchases

Q2 2025
State Street Corp Shares Held: 10.7M ($49.3M)
Q2 2025
Morgan Stanley Shares Held: 2.76M ($12.7M)
Q2 2025
Vanguard Group Inc Shares Held: 18.2M ($83.4M)
Q2 2025
Royal Bank Of Canada Shares Held: 1.04M ($4.79M)
Q2 2025
Geode Capital Management, LLC Shares Held: 7.62M ($35M)

Top Sells

Q2 2025
Ubs Group Ag Shares Held: 2.11M ($9.67M)
Q2 2025
Avoro Capital Advisors LLC Shares Held: 5.85M ($26.9M)
Q2 2025
Arrowstreet Capital, Limited Partnership Shares Held: 1.1M ($5.05M)
Q2 2025
Millennium Management LLC Shares Held: 4.48M ($20.6M)
Q2 2025
D. E. Shaw & Co., Inc. Shares Held: 2.52M ($11.6M)

About MNKD

MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocrinologists, and other healthcare providers for the treatment of hypothyroidism. The company has a license and collaboration agreement with United Therapeutics Corporation. It also has an agreement with NRx Pharmaceuticals to develop a dry powder formulation of ZYESAMI (aviptadil), a synthetic form of human vasoactive intestinal peptide to help protect cells against inflammatory conditions. MannKind Corporation was incorporated in 1991 and is headquartered in Westlake Village, California.


Insider Transactions at MNKD

Insider Transaction List

View all
Date Insider Transaction Ownership Type Shares Traded Value / Price
View All Transactions

Last 12 Months Summary

Buy / Acquisition
2.05M Shares
From 9 Insiders
Grant, award, or other acquisition 1.92M shares
Exercise of conversion of derivative security 135K shares
Sell / Disposition
1.88M Shares
From 14 Insiders
Payment of exercise price or tax liability 1.15M shares
Open market or private sale 664K shares
Bona fide gift 32.9K shares
Other acquisition or disposition 39.5K shares

Track Institutional and Insider Activities on MNKD

Follow MANNKIND CORP and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells MNKD shares.

Notify only if

Insider Trading

Get notified when an Mannkind Corp insider buys or sells MNKD shares.

Notify only if

News

Receive news related to MANNKIND CORP

Track Activities on MNKD